{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:59:12Z","timestamp":1784552352154,"version":"3.55.0"},"reference-count":18,"publisher":"The Japan Geriatrics Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. geriat","Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3143\/geriatrics.52.153","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T22:02:55Z","timestamp":1431986575000},"page":"153-161","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum \u03b2-lactamase producing (ESBL-) &lt;i&gt;Escherichia coli&lt;\/i&gt;: A comparison between meropenem and alternatives"],"prefix":"10.3143","volume":"52","author":[{"given":"Akira","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Blueberry, Amagasaki Health Care Facilities for the Elderly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Blueberry, Amagasaki Health Care Facilities for the Elderly"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Pfaller MA, Segreti J: Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 2006; 42 (Suppl 4): S153-163.","DOI":"10.1086\/500662"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Niki M, Hirai I, Yosinaga A, Ulzii-Orshikh L, Nakata A, Yamamoto A, et al.: Extended-spectrum \u03b2-lactamase-producing <i>Escherichia coli<\/i> strains in the feces of carriers contribute substantially to urinary tract infections in these patients. Infection 2011; 39: 467-471.","DOI":"10.1007\/s15010-011-0128-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Rooney PJ, O&apos;Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, et al.: Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL) -producing ciprofloxacin-resistant <i>Escherihia coli<\/i>. J Antimicrob Chemother 2009; 64: 635-641.","DOI":"10.1093\/jac\/dkp220"},{"key":"4","doi-asserted-by":"crossref","unstructured":"6) Horcajada JP, Moreno I, Velasco M, Martinez JA, Moreno-Martinez A, Barranco M, et al.: Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med 2003; 254: 280-286.","DOI":"10.1046\/j.1365-2796.2003.01197.x"},{"key":"5","first-page":"67","volume":"6","author":"U-O Luvsansharav","year":"2013","unstructured":"7) Luvsansharav U-O, Hirai I, Niki M, Nakata A, Yoshinaga A, et al.: Fecal carriage of CTX-M \u03b2-lactamase producing enterobacteriaceae in nursing homes in Kinki region of Japan. Infection and Drug Resistance 2013; 6: 67-70.","journal-title":"Infection and Drug Resistance","ISSN":"https:\/\/id.crossref.org\/issn\/1178-6973","issn-type":"print"},{"key":"6","doi-asserted-by":"publisher","unstructured":"8) Baldwin CM, Lyseng-Williamson KA, Keam SJ: Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 2008; 68: 803-838.","DOI":"10.2165\/00003495-200868060-00006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9) Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, et al.: Risk associated with a systematic search of extended-spectrum \u03b2-lactamase-producing <i>Enterobacteriaceae<\/i>. Am J Infect Control 2013; 41: 259-260.","DOI":"10.1016\/j.ajic.2012.03.035"},{"key":"8","doi-asserted-by":"crossref","unstructured":"11) Fournier D, Chirouze C, Leroy J, Cholley P, Talon D, Pl\u00e9siat P, et al.: Alternatives to carbapenems in ESBL-producing <i>Escherichia coli<\/i> infections. Med Mal Infect 2013; 43: 62-66.","DOI":"10.1016\/j.medmal.2013.01.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"12) Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y: Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing <i>Klebsiella<\/i> species in hospitalized patients. Antimicrob Agents Chemother 2010; 54: 2010-2016.","DOI":"10.1128\/AAC.01131-09"},{"key":"10","doi-asserted-by":"crossref","unstructured":"13) Goulenok T, Ferroni A, Bille E, L\u00e9cuyer H, Join-Lambert O, Descamps P, et al.: Risk factors for developing ESBL <i>E Coli<\/i>: can clinicians predict infection in patients with prior colonization? J Hosp Infection 2013; 84: 294-299.","DOI":"10.1016\/j.jhin.2013.04.018"},{"key":"11","doi-asserted-by":"crossref","unstructured":"14) Yang Q, Zhang H, Wang Y, Xu Y, Chen M, Badal RE, et al.: A 10 year surveillance for antimicrobial susceptibility of <i>Escherichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> in community- and hospital-associated intra-abdominal infections in China. J Med Microbiol 2013; 62: 1343-1349.","DOI":"10.1099\/jmm.0.059816-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"15) Chopra T, Marchaim D, Veltman J, Johnson P, Zhao JJ, Tansek R, et al.: Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing <i>Klebsiella pneumoniae<\/i> and <i>Escherichia coli<\/i>. Antimicrob Agents Chemother 2012; 56: 3936-3942.","DOI":"10.1128\/AAC.05419-11"},{"key":"13","doi-asserted-by":"crossref","unstructured":"16) Eagye KJ, Kuti JL, Nicolau DP: Risk factors and outcomes associated with isolation of meropenem high-level-resistant <i>pseudomonas aeruginosa<\/i>. Infect Control Hosp Epidemiol 2009; 30: 746-752.","DOI":"10.1086\/603527"},{"key":"14","doi-asserted-by":"crossref","unstructured":"18) Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME: Carbapenems versus alternative antibiotics for the treatment of bacteremia due to <i>Enterobacteriaceae<\/i> producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother 2012; 67: 2793-2803.","DOI":"10.1093\/jac\/dks301"},{"key":"15","unstructured":"19) Araj GF, Jaber FA: In vitro activity of fosfomycin and other antimicrobials against uropathogenic <i>Escherichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> at a tertiary care center in Lebanon. J Med Liban 2012; 60: 142-147."},{"key":"16","doi-asserted-by":"crossref","unstructured":"20) P\u00f6rnull KJ, Rodrigo G, Dornbusch K: Production of a plasmid mediated AmpC-like beta-lactamase by a <i>Klebsiella pneumoniae<\/i> septicaemia isolate. J Antimicrob Chemother 1994; 34: 943-954.","DOI":"10.1093\/jac\/34.6.943"},{"key":"17","doi-asserted-by":"crossref","unstructured":"21) Lee CH, Chu C, Liu JW, Chen YS, Chiu CJ, Su LH: Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of <i>Klebsiella pneumoniae<\/i> producing CTX-M-3 and SHV-5 beta-lactamases. J Antimicrob Chemother 2007; 60: 410-413.","DOI":"10.1093\/jac\/dkm215"},{"key":"18","doi-asserted-by":"crossref","unstructured":"22) Pe\u0144a C, Gudiol C, Calatayud L, Tubau F, Dominguez MA, Pujal M, et al.: Infections due to <i>Escherichia coli<\/i> producing extended-spectrum beta-lactamase among hospitalized patients: factors influencing mortality. J Hospital Infect 2008; 68: 116-122.","DOI":"10.1016\/j.jhin.2007.11.012"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":["ESBL\u7523\u751f\/\u30ad\u30ce\u30ed\u30f3\u8010\u6027\u5927\u8178\u83cc\u306e\u5b58\u5728\u3092\u898b\u636e\u3048\u305f\u9ad8\u9f62\u8005\u5c3f\u8def\u611f\u67d3\u75c7\u306e\u6297\u83cc\u85ac\u6cbb\u7642\u3092\u8003\u5bdf\u3059\u308b"],"language":"en","deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T07:51:54Z","timestamp":1566719514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/52\/2\/52_153\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.52.153","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}